# Nippon Sanso Matheson, Inc. – FDA Inspection, Feb 10, 2017

Source: https://www.keypedia.com/records/fda_inspections/nippon-sanso-matheson-inc/3b6d9caa-20e3-4639-8cfc-7bad604840b4
Source feed: FDA_Inspections

> FDA inspection 1002295 of Nippon Sanso Matheson, Inc., February 10, 2017. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1002295
- Company Name: Nippon Sanso Matheson, Inc.
- Inspection Date: 2017-02-10
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 3

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/gloria-j-baca/1b8c62dc-3195-4364-924d-1d53dd6a7f60)

Company: https://www.keypedia.com/companies/nippon-sanso-matheson-inc/f395e2c7-d9ca-45c1-a953-05be9b9b9b37

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c